{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:34:28Z","timestamp":1773693268890,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.drugalcdep.2007.09.020","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T16:36:56Z","timestamp":1196959016000},"page":"246-250","source":"Crossref","is-referenced-by-count":27,"title":["Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers"],"prefix":"10.1016","volume":"94","author":[{"given":"Deborah C.","family":"Mash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Adi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Duque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Pablo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank R.","family":"Ervin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2007.09.020_bib1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/01.ALC.0000164360.43907.24","article-title":"Alpha-synuclein protein levels are increased in alcoholic patients and are linked to craving","volume":"29","author":"Bonsch","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/hmg\/ddi090","article-title":"Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence","volume":"14","author":"Bonsch","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00001756-200502080-00020","article-title":"DNA hypermethylation of the alpha synuclein promoter in patients with alcoholism","volume":"16","author":"Bonsch","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.biopsych.2004.09.016","article-title":"Elevated alpha synuclein mRNA levels are associated with craving in patients with alcoholism","volume":"56","author":"Bonsch","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.drugalcdep.2007.09.020_bib5","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1212\/WNL.54.12.2285","article-title":"Differential effects of cocaine and cocaine alcohol on neurocognitive performance","volume":"54","author":"Bolla","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0888-7543(95)80237-G","article-title":"The human NACP\/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis","volume":"26","author":"Chen","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1530-0277.2007.00338.x","article-title":"Linkage disequilibrium and association analysis of alpha-synuclein and alcohol and drug dependence in two American Indian populations","volume":"31","author":"Clarimon","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(03)00684-6","article-title":"Caught in the act: alpha-synuclein is the culprit in Parkinson's disease","volume":"40","author":"Eriksen","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"Drosophila model of Parkinson's disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.drugalcdep.2007.09.020_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365510601161497","article-title":"Determination of alpha-synuclein concentration in human plasma using ELISA","volume":"67","author":"Fjorback","year":"2007","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1530-0277.2000.tb04634.x","article-title":"Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping","volume":"24","author":"Foroud","year":"2000","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1530-0277.2007.00337.x","article-title":"Association of alcohol craving with alpha-synuclein (SNCA)","volume":"31","author":"Foroud","year":"2007","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0010-440X(91)90066-L","article-title":"The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale","volume":"32","author":"Halikas","year":"1991","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1471-4159.1991.tb08205.x","article-title":"Cocaethylene: A unique cocaine metabolite displays high affinity for the dopamine transporter","volume":"56","author":"Hearn","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib15","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1021\/bi972776r","article-title":"Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins","volume":"37","author":"Jenco","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1196\/annals.1316.040","article-title":"Study of association between alpha-synuclein gene polymorphism and methamphetamine psychosis\/dependence","volume":"1025","author":"Kobayashi","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1101\/gr.8.9.871","article-title":"The synuclein family","volume":"8","author":"Lavedan","year":"1998","journal-title":"Genome Res."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib18","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1096\/fj.00-0334com","article-title":"Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis","volume":"15","author":"Lee","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.expneurol.2006.12.006","article-title":"Plasma alpha-synuclein is decreased in subjects with Parkinson's disease","volume":"204","author":"Li","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib20","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1073\/pnas.0737182100","article-title":"Alpha-synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats","volume":"100","author":"Liang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0169-328X(91)90043-W","article-title":"The rat brain synucleins; family of proteins transiently associated with neuronal membrane","volume":"11","author":"Maroteaux","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib22","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1523\/JNEUROSCI.23-07-02564.2003","article-title":"Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons","volume":"23","author":"Mash","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib25","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1212\/01.WNL.0000127517.33208.F4","article-title":"Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication","volume":"62","author":"Miller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/JMN:25:2:157","article-title":"Peripheral sensory neurons survive in the absence of alpha- and gamma-synucleins","volume":"25","author":"Papachroni","year":"2005","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib27","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"issue":"13","key":"10.1016\/j.drugalcdep.2007.09.020_bib28","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1097\/01.wnr.0000175617.39054.ba","article-title":"Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in human striatum","volume":"16","author":"Qin","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.ne.18.030195.002335","article-title":"Molecular mechanisms of drug reinforcement and addiction","volume":"18","author":"Self","year":"1995","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000134061","article-title":"High-resolution mapping of SNCA encoding alpha-synuclein, the non-A beta component of Alzheimer's disease amyloid precursor, to human chromosome 4q21.3-->q22 by fluorescence in situ hybridisation","volume":"71","author":"Shibasaki","year":"1995","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.febslet.2004.03.063","article-title":"Alpha-synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease","volume":"565","author":"Sidhu","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/geno.1995.1063","article-title":"Assignment of human alpha-synuclein (SNCA) and beta-synuclein (SNCB) genes to chromosomes 4q21 and 5q35","volume":"27","author":"Spillantini","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jama.294.15.1898","article-title":"Classification of psychiatric disorders","volume":"294","author":"Spitzer","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib34","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/324467","article-title":"Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms","volume":"69","author":"Uhl","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3565(24)35115-8","article-title":"Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors","volume":"291","author":"Volkow","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.alcohol.2006.03.008","article-title":"Peripheral blood alpha-synuclein mRNA levels are elevated in cynomolgus monkeys that chronically self-administer ethanol","volume":"38","author":"Walker","year":"2006","journal-title":"Alcohol"},{"key":"10.1016\/j.drugalcdep.2007.09.020_bib37","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1523\/JNEUROSCI.2559-04.2004","article-title":"Role of alpha-synuclein in presynaptic dopamine recruitment","volume":"24","author":"Yavich","year":"2004","journal-title":"J. Neurosci."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871607004140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871607004140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T09:07:39Z","timestamp":1737623259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871607004140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":37,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0376871607004140"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2007.09.020","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}